APA (7th ed.) Citation

van Veggel, B. A. M. H., van der Wekken, A. J., Paats, M. S., Hendriks, L. E. L., Hashemi, S. M. S., Daletzakis, A., . . . de Langen, A. J. (2024). A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion–positive non–small cell lung cancer. Cancer (0008543X), 130(5), 683. https://doi.org/10.1002/cncr.35090

Chicago Style (17th ed.) Citation

van Veggel, Bianca A. M. H., et al. "A Phase 2 Trial Combining Afatinib with Cetuximab in Patients with EGFR Exon 20 Insertion–positive Non–small Cell Lung Cancer." Cancer (0008543X) 130, no. 5 (2024): 683. https://doi.org/10.1002/cncr.35090.

MLA (9th ed.) Citation

van Veggel, Bianca A. M. H., et al. "A Phase 2 Trial Combining Afatinib with Cetuximab in Patients with EGFR Exon 20 Insertion–positive Non–small Cell Lung Cancer." Cancer (0008543X), vol. 130, no. 5, 2024, p. 683, https://doi.org/10.1002/cncr.35090.